top of page

Topic

Glucagon-Like Peptide-1 Agonists (GLP-1)

18 Podcasts • 1 Case • 1 Course on BackTable

Integrating GLP-1s in Obesity & OSA Management
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable ENT & Allergy

Episode # 291  •  08 Sept 2026

Integrating GLP-1s in Obesity & OSA Management

Which patients with obstructive sleep apnea are candidates for a GLP-1, and how do you start, escalate, and monitor one safely? On this episode of BackTable ENT & Allergy, host Dr. Gopi Shah is joined by obesity medicine specialist Dr. Shanail Berry and sleep specialist Dr. John Carter to discuss the practical questions that arise when adding GLP-1 and GLP/GIP therapies in OSA management. They discuss drug mechanisms and formulations, patient selection, screening and referral, management of side effects and contraindications, adherence strategies, perioperative considerations, and nutritional issues.

More on Glucagon-Like Peptide-1 Agonists (GLP-1)

Loading recent podcasts…

ENT

ENT & Allergy # 291

Sep 7, 2026

with Dr. Shanail Berry, Dr. John Carter, Dr. Gopi Shah

Integrating GLP-1s in Obesity & OSA Management

Which patients with obstructive sleep apnea are candidates for a GLP-1, and how do you start, escalate, and monitor one...

Tumor Board

Tumor Board # 70

Jun 29, 2026

with Dr. Chih-Yi Liao, Dr. Xavier Keutgen, Dr. Lingling Du

Diagnosis & Initial Management of Neuroendocrine Tumors

How do you unravel the complexity of diagnosing and managing neuroendocrine tumors, where every case demands a tailored...

Curbsiders

Curbsiders # 523

Apr 26, 2026

with Dr. Shani Herzig, Dr. Rahul Ganatra, Dr. Matthew Watto, Dr. Paul Williams

Hotcakes: Left Atrial Appendage Closure vs AC for Afib, Apixaban vs Rivaroxaban for VTE, Intensive LDL Targeting, GLP1s & Substance Use Disorders & More

Join us as we review recent practice-changing articles on left atrial appendage closure vs AC for AFib, apixaban vs...

Curbsiders

Curbsiders # 517

Mar 15, 2026

with Dr. Nora Taranto, Dr. Alex Chaitoff, Dr. Matthew Watto, Dr. Paul Williams

Physical Performance, Fall Risk

Join us as we review and appraise recent practice-changing articles. In this episode, we cover the latest in GLP-1s and...

Curbsiders

Curbsiders # 536

Aug 16, 2026

with Dr. Shawn Cohen, Dr. Zina Huxley-Reicher, Dr. Carolyn Chan, Dr. Era Kryzhanovskaya

Q&Apalooza: Your Addiction Questions Answered!

This episode explores complex questions around addiction treatment from our audience, including the off-label use of...

Curbsiders

Curbsiders # 526

May 24, 2026

with Dr. Nora Taranto, Dr. Laura Glick, Dr. Matthew Watto

DIGEST – Game Changers in Pancreatic Cancer, Lipid Guideline Updates & GLP-1/GIP Endoscopy Holds

Join us as we review recent articles and news featured in The DIGEST, including updated lipid guidelines, GLP1 agonists...

Tumor Board

Tumor Board # 55

Apr 13, 2026

with Dr. Shruti Patel, Dr. Jun Gong

Updates in Colorectal Cancer Management: Insights from ASCO GI

How will the newest colorectal cancer trial results discussed at the 2026 ASCO GI Cancers Symposium in San Francisco...

Cardiology

Cardiology # 21

Jan 19, 2026

with Dr. Jessica Huston, Dr. Hady Lichaa

Current HFpEF Treatments: Clinical Pearls & Progress

If your New Year’s resolution involves learning more about current practice guidelines and emerging research on Heart...

Tumor Board

Tumor Board Case

Jun 29, 2026

PNET: Locally Advanced Pancreatic Neuroendocrine Tumor in Morbidly Obese Male, 10cm Mass Abutting Multiple Structures

with Dr. Chih-Yi Liao, Dr. Xavier Keutgen and Dr. Lingling Du

Management of Obstructive Sleep Apnea (OSA)

ENT Course

2 hours, 24 lessons

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page